Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing

Allogeneic T cells are key immune therapeutic cells to fight cancer and other clinical indications. High T cell dose per patient and increasing patient numbers result in clinical demand for a large number of allogeneic T cells. This necessitates a manufacturing platform that can be scaled up while r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatla, Himavanth, Uth, Nicholas, Levinson, Yonatan, Navaei, Ali, Sargent, Alex, Ramaswamy, Senthil, Friedrich Ben-Nun, Inbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189297/
https://www.ncbi.nlm.nih.gov/pubmed/35707712
http://dx.doi.org/10.3389/fmedt.2022.850565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189297/
https://www.ncbi.nlm.nih.gov/pubmed/35707712
http://dx.doi.org/10.3389/fmedt.2022.850565

Ejemplares similares